Skip to main content
Top

Endocrine

Issue 1/2003

Content (14 Articles)

Introduction

Thérèse Di Paolo

Estrogen and selective estrogen receptor modulators

Stephanie J. Murphy, Louise D. McCullough, Marguerite T. Littleton-Kearney, Patricia D. Hurn

Functional aspects of estrogen neuroprotection

Veronica Bisagno, Rachel E. Bowman, Victoria N. Luine

Endogenous estrogen formation is neuroprotective in model of cerebellar ataxia

Amanda Sierra, Íñigo Azcoitia, Luis Miguel Garcia-Segura

Chronic but not acute estradiol treatment protects against the neurodegenerative effects of N-methyl-d-aspartate receptor antagonists

William H. Dribben, Brian M. Nemmers, Anthony R. Nardi, George T. Taylor, John W. Olney, Nuri B. Farber

Neuroprotective effects of estrogen and tamoxifen in vitro

Krishnan M. Dhandapani, Darrell W. Brann

Estrogen as neuroprotectant of nigrostriatal dopaminergic system

Dean E. Dluzen, Martin W. I. M. Horstink

Estrogens and parkinson disease

Hideyuki Sawada, Shun Shimohama

Estrogens and parkinson disease

Rachel Saunders-Pullman

Effects of estradiol, phytoestrogens, and ginkgo biloba extracts against 1-methyl-4-phenyl-pyridine-induced oxidative stress

Benoît Gagné, Sylvie Gélinas, Geneviéve Bureau, Bruno Lagacé, Charles Ramassamy, Keith Chiasson, Barbara Valastro, Maria-Grazia Martinoli

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.